首页> 外国专利> METHOD OF NORMALISING FUNCTIONAL RESPONSIVENESS OF CARDIOVASCULAR SYSTEM IN ARTERIAL HYPERTENSION

METHOD OF NORMALISING FUNCTIONAL RESPONSIVENESS OF CARDIOVASCULAR SYSTEM IN ARTERIAL HYPERTENSION

机译:规范动脉高压中心血管系统功能反应的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, particularly to cardiology, and concerns normalising the functional responsiveness of cardiovascular system in arterial hypertension. That is ensured by estimating the condition of functional responsiveness of the CVS in psychoemotional load by recording systolic, diastolic, average dynamic pressure and heart rate (HR). These data are used to evaluate a functional responsiveness index (FRI) before and after load by formula: FRI=(BPav.dyn. x HR)100 (standard units). When observing the FRI gain by 20 standard units and more, losartan is prescribed in dosage 50 mg in the morning once a day and lacidipine in dosage 2 mg in the morning once a day for at least 2 months.;EFFECT: complex of drug-induced therapy combined with empirically prescribed treatment length provides normalisation of functional responsiveness of the CVS in the given group of the patients due to potentiation of therapeutic effect of the used drugs.;2 ex
机译:技术领域本发明涉及医学,尤其是心脏病学,并且涉及使动脉高血压中的心血管系统的功能反应性正常化。通过记录收缩期,舒张期,平均动压和心率(HR)来估算心理情绪负荷中CVS的功能反应状况,从而确保这一点。这些数据用于通过公式FRI =(BPav.dyn.x HR)100(标准单位)评估加载前后的功能响应指数(FRI)。当观察到FRI的增加量达到20个标准单位或更多时,每天一次,每天一次洛沙坦的剂量为50 mg,每天一次,一次拉西地平的剂量为2 mg,持续至少2个月。归因于所用药物治疗效果的增强,诱导疗法与经验规定的治疗时间相结合,可使给定患者组中CVS的功能反应正常化; 2 ex

著录项

  • 公开/公告号RU2392934C1

    专利类型

  • 公开/公告日2010-06-27

    原文格式PDF

  • 申请/专利权人 MEDVEDEV ILJA NIKOLAEVICH;

    申请/专利号RU20090109465

  • 发明设计人 MEDVEDEV ILJA NIKOLAEVICH;

    申请日2009-03-16

  • 分类号A61K31/216;A61K31/4155;A61P9/12;

  • 国家 RU

  • 入库时间 2022-08-21 18:29:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号